58 related articles for article (PubMed ID: 17560548)
21. Identification of the tetraspanin CD82 as a new barrier to xenotransplantation.
Saleh SM; Parhar RS; Al-Hejailan RS; Bakheet RH; Khaleel HS; Khalak HG; Halees AS; Zaidi MZ; Meyer BF; Yung GP; Seebach JD; Conca W; Khabar KS; Collison KS; Al-Mohanna FA
J Immunol; 2013 Sep; 191(5):2796-805. PubMed ID: 23872050
[TBL] [Abstract][Full Text] [Related]
22. Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies.
Detchokul S; Williams ED; Parker MW; Frauman AG
Br J Pharmacol; 2014 Dec; 171(24):5462-90. PubMed ID: 23731188
[TBL] [Abstract][Full Text] [Related]
23. An automated cell-counting algorithm for fluorescently-stained cells in migration assays.
Al-Khazraji BK; Medeiros PJ; Novielli NM; Jackson DN
Biol Proced Online; 2011 Oct; 13(1):9. PubMed ID: 22011343
[TBL] [Abstract][Full Text] [Related]
24. Dissecting the diverse functions of the metastasis suppressor CD82/KAI1.
Tsai YC; Weissman AM
FEBS Lett; 2011 Oct; 585(20):3166-73. PubMed ID: 21875585
[TBL] [Abstract][Full Text] [Related]
25. Alkaline ceramidase 2 regulates beta1 integrin maturation and cell adhesion.
Sun W; Hu W; Xu R; Jin J; Szulc ZM; Zhang G; Galadari SH; Obeid LM; Mao C
FASEB J; 2009 Feb; 23(2):656-66. PubMed ID: 18945876
[TBL] [Abstract][Full Text] [Related]
26. The tumour-associated antigen L6 (L6-Ag) is recruited to the tetraspanin-enriched microdomains: implication for tumour cell motility.
Lekishvili T; Fromm E; Mujoomdar M; Berditchevski F
J Cell Sci; 2008 Mar; 121(Pt 5):685-94. PubMed ID: 18270265
[TBL] [Abstract][Full Text] [Related]
27. KAI1/CD82, Metastasis Suppressor Gene as a Therapeutic Target for Non-Small-Cell Lung Carcinoma.
Prabhu VV; Devaraj SN
J Environ Pathol Toxicol Oncol; 2017; 36(3):269-275. PubMed ID: 29283339
[TBL] [Abstract][Full Text] [Related]
28. KAI1/CD82 decreases Rac1 expression and cell proliferation through PI3K/Akt/mTOR pathway in H1299 lung carcinoma cells.
Choi UJ; Jee BK; Lim Y; Lee KH
Cell Biochem Funct; 2009 Jan; 27(1):40-7. PubMed ID: 19107873
[TBL] [Abstract][Full Text] [Related]
29. KAI1/CD82 suppresses tumor invasion by MMP9 inactivation via TIMP1 up-regulation in the H1299 human lung carcinoma cell line.
Jee BK; Park KM; Surendran S; Lee WK; Han CW; Kim YS; Lim Y
Biochem Biophys Res Commun; 2006 Apr; 342(2):655-61. PubMed ID: 16488391
[TBL] [Abstract][Full Text] [Related]
30. EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells.
Zhang XA; Lane WS; Charrin S; Rubinstein E; Liu L
Cancer Res; 2003 May; 63(10):2665-74. PubMed ID: 12750295
[TBL] [Abstract][Full Text] [Related]
31. The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity.
Zhou B; Liu L; Reddivari M; Zhang XA
Cancer Res; 2004 Oct; 64(20):7455-63. PubMed ID: 15492270
[TBL] [Abstract][Full Text] [Related]
32. Effect of KAI1/CD82 on the beta1 integrin maturation in highly migratory carcinoma cells.
Jee BK; Lee JY; Lim Y; Lee KH; Jo YH
Biochem Biophys Res Commun; 2007 Aug; 359(3):703-8. PubMed ID: 17560548
[TBL] [Abstract][Full Text] [Related]
33. KAI1/CD82, a tumor metastasis suppressor.
Liu WM; Zhang XA
Cancer Lett; 2006 Aug; 240(2):183-94. PubMed ID: 16260083
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
